A new series of 1,3-dihidro-imidazo[1,5-c]thiazole-5,7-dione derivatives: Synthesis and interaction with Aβ(25-35) amyloid peptide

Chemical Biology and Drug Design

Volumn 74, Issue 3, 2009, Pages 224-233

  Campiglia, Pietro ^a   Scrima, Mario ^a   Grimaldi, Manuela ^a   Cioffi, Giuseppina ^a   Bertamino, Alessia ^b   Sala, Marina ^a   Aquino, Claudio ^b   Gomez Monterrey, Isabel ^b   Grieco, Paolo ^b   Novellino, Ettore ^b   D'Ursi, Anna Maria ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

amyloid peptide; A (25 35); Fibril modulators; Interaction

Indexed keywords

ALIPHATIC AMINE; AMYLOID BETA PROTEIN[25-35]; THIAZOLE DERIVATIVE;

ARTICLE; CIRCULAR DICHROISM; DRUG PROTEIN BINDING; DRUG SYNTHESIS; FLUORESCENCE SPECTROSCOPY; MOLECULAR DOCKING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

AMYLOID BETA-PROTEIN; CIRCULAR DICHROISM; COMPUTER SIMULATION; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; PEPTIDE FRAGMENTS; PROTEIN BINDING; THIAZOLES;

EID: 68949199661     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2009.00853.x     Document Type: Article

References (49)

1. Selkoe D.J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 : 741 766.
2. Walsh D., Selkoe D. (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 : 181 193.
3. Sipe J.D., Cohen A.S. (2000) Review: history of the amyloid fibril. J Struct Biol 130 : 88 98.
4. Hardy J., Selkoe D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 : 353 356.
5. Selkoe D.J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 : A23 A31.
6. Iversen L.L., Mortishire-Smith R.J., Pollack S.J., Shearman M.S. (1995) The toxicity in vitro of beta-amyloid protein. Biochem J 311 (Pt 1 1 16.
7. Kirschner D.A., Abraham C., Selkoe D.J. (1986) X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc Natl Acad Sci USA 83 : 503 507.
8. Soto C., Castano E.M., Frangione B., Inestrosa N.C. (1995) The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J Biol Chem 270 : 3063 3067.
9. Tomaselli S., Esposito V., Vangone P., van Nuland N.A., Bonvin A.M., Guerrini R., Tancredi T., Temussi P.A., Picone D. (2006) The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Chembiochem 7 : 257 267.
10. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 : 535 539.
11. De Lorenzi E., Giorgetti S., Grossi S., Merlini G., Caccialanza G., Bellotti V. (2004) Pharmaceutical strategies against amyloidosis: old and new drugs in targeting a 'protein misfolding disease'. Curr Med Chem 11 : 1065 1084.
12. Soto C., Estrada L. (2005) Amyloid inhibitors and beta-sheet breakers. Subcell Biochem 38 : 351 364.
13. Arkin M.R., Wells J.A. (2004) Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 3 : 301 317.
14. Mason J.M., Kokkoni N., Stott K., Doig A.J. (2003) Design strategies for anti-amyloid agents. Curr Opin Struct Biol 13 : 526 532.
15. Stains C.I., Mondal K., Ghosh I. (2007) Molecules that target beta-amyloid. ChemMedChem 2 : 1674 1692.
16. D'Ursi A.M., Armenante M.R., Guerrini R., Salvadori S., Sorrentino G., Picone D. (2004) Solution structure of amyloid beta-peptide (25-35) in different media. J Med Chem 47 : 4231 4238.
17. D'Ursi A.M., Armenante M.R., Esposito C., Montoro P., Piacente S., Pizza C., Picone D. (2005) Modulation of the conformational behaviour of Aβ(25-35) by interaction with natural compounds. In : Peptides 2004 Proceedings of the Third International and Twenty-eight European Peptides Symposium. Geneva : Kenes International p. 451 452.
18. Terzi E., Holzemann G., Seelig J. (1994) Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry 33 : 7434 7441.
19. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13 : 1676 1687.
20. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. (1995) Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 64 : 253 265.
21. Campiglia P., Esposito C., Scrima M., Gomez-Monterrey I., Bertamino A., Grieco P., Novellino E., D'Ursi A.M. (2007) Conformational stability of Abeta-(25-35) in the presence of thiazolidine derivatives. Chem Biol Drug Des 69 : 111 118.
22. Chan W., White P. (2000) Fmoc solid phase peptide synthesis: a practical approach. New York : Oxford University Press.
23. Zagorski M.G., Yang J., Shao H., Ma K., Zeng H., Hong A. (1999) Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity. Methods Enzymol 309 : 189 204.
24. Naiki H., Nakakuki K. (1996) First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. Lab Invest 74 : 374 383.
25. Whitmore L., Wallace B. (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32 : W668 W673.
26. Bax A., Davis D. (1985) MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Reson 65 : 355 360.
27. Macura S., Ernst R. (1980) Elucidation of cross-relaxation in liquids by two-dimensional NMR. Mol Phys 41 : 95 117.
28. Jeener J., Meier B., Bachmann P., Ernst R. (1979) Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys 71 : 4546.
29. Goddard T., Kneller D. (2004) SPARKY 3. San Francisco : University of California.
30. Halgren T. (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17 : 490 519.
31. Frisch M., Trucks G., Schlegel H., Scuseria G., Robb M., Cheeseman J., Montgomery J Jr., Vreven T., Kudin K., Burant J. (2003) Gaussian 03, Revision A. 1. Pittsburgh, PA : Gaussian Inc.
32. Breneman C., Wiberg K. (1990) Determining atom-centered monopoles from molecular electrostatic potentials. The need for high sampling density in formamide conformational analysis. J Comput Chem 11 : 361 373.
33. Morris G., Goodsell D., Halliday R., Huey R., Hart W., Belew R., Olson A. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19 : 1639 1662.
34. Sanner M. (1999) Python: a programming language for software integration and development. J Mol Graph Model 17 : 57 61.
35. Pettersen E., Goddard T., Huang C., Couch G., Greenblatt D., Meng E., Ferrin T. (2004) UCSF Chimera: a visualization system for exploratory research and analysis. J Comput Chem 25 : 1605 1612.
36. Sanner M., Olson A., Spehner J. (1996) Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38 : 305 320.
37. Gilchrist T., Rocha Gonsalves A., Pinho e Melo T. (1994) Diels-Alder reactions of 2-azadienes derived from cysteine and serine methyl esters and aldehydes. Tetrahedron 50 : 13709 13724.
38. Majer P., Randad R. (1994) A safe and efficient method for preparation of N,N′-unsymmetrically disubstituted ureas utilizing triphosgene. J Org Chem 59 : 1937 1938.
39. Pátek M., Drake B., Lebl M. (1995) Solid-phase synthesis of 'small' organic molecules based on thiazolidine scaffold. Tetrahedron Lett 36 : 2227 2230.
40. Miskolczi I., Zekany A., Rantal F., Linden A., Kover K., Gyorgydeak Z. (1998) Diastereo-and regioisomeric bicyclic thiohydantoins from chiral 1,3-thiazolidine-2,4-dicarboxylic acids. Helv Chim Acta 81 : 744 753.
41. Bax A., Davis D., Sarkar S. (1985) An improved method for two-dimensional heteronuclear relayed-coherence-transfer NMR spectroscopy. J Magn Reson 63 : 230 234.
42. Palmer A., Cavanagh J., Wright P., Rance M. (1991) Sensitivity improvement in proton-detected two-dimensional heteronuclear correlation NMR spectroscopy. J Magn Reson 93 : 151 170.
43. Schleucher J., Schwendinger M., Sattler M., Schmidt P., Schedletzky O., Glaser S., Sørensen O., Griesinger C. (1994) A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients. J Biomol NMR 4 : 301 306.
44. Wüthrich K. (1986) NMR of Proteins and Nucleic Acids. New York : John Willey and Sons.
45. Soto C., Kindy M., Baumann M., Frangione B. (1996) Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem Biophys Res Commun 226 : 672 680.
46. LeVine H. (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin. Methods Enzymol 309 : 274 284.
47. Levine H III. (1993) Thioflavine T interaction with synthetic Alzheimer's disease ß-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2 : 404 410.
48. Necula M., Kayed R., Milton S., Glabe C.G. (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282 : 10311 10324.
49. Glabe C. (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283 : 29639 29643.